02:25 PM EDT, 10/17/2024 (MT Newswires) -- Sonnet BioTherapeutics Holdings ( SONN ) said Thursday the Nasdaq Stock Market has informed the company that it has regained compliance with the minimum bid price requirement for continued listing on the exchange.

The company's shares were up about 25% in recent trading.

Price: 6.35, Change: +1.27, Percent Change: +25.00